Oral vinorelbine (NVBO) in combination with trastuzumab (HER) in metastatic breast cancer (MBC): Data on efficacy and safety when administered in first- or second-line treatment.

被引：2
|
作者：
Illarramendi, J. J.
Blancas, I.
Bueso, P.
Carabantes, F.
Polo Marques, E.
Ciruelos Gil, E.
Corral, M.
Perez, F. J.
机构：
[1] Hosp Navarra, Pamplona, Spain
[2] Hosp Univ Clin San Cecilio, Granada, Spain
[3] Hosp Barbastro, Barbastro, Spain
[4] Hosp Univ Carlos Haya, Malaga, Spain
[5] Hosp Ernest Lluch, Calatayud, Spain
[6] Hosp 12 Octubre, E-28041 Madrid, Spain
[7] Hosp Alcaniz, Alcaniz, Spain
[8] Inst Catala Oncol, Clin Res Unit, Lhospitalet De Llobregat, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e11508
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11508
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of oral vinorelbine (NVBO) in first- or second-line metastatic breast cancer (MBC)
    Blancas, I.
    Morales, S.
    Diaz, N.
    Barnadas, A.
    Gonzalvez, M. L.
    del Barco, S.
    Lopez de Ceballos, M. H.
    Perez, F. J.
    Llombart-Cussac, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Efficacy and safety of weekly oral vinorelbine (NVBO) as single agent in first- or second-line metastatic breast cancer (MBC)
    Morales, Serafin
    Blancas, Isabel
    Luisa Gonzalvez, Maria
    Barnadas, Agust
    Diaz, Nieves
    Servitja, Sonia
    del Barco, Sonia
    Margeli, Mireia
    Garcia Carbonero, Iciar
    Alvarez, Ruth
    Helena Lopez de Ceballos, Maria
    Javier Perez, Francisco
    Llombart Cussac, Antonio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] First-line trastuzumab (H), oral vinorelbine (NVBo) and capecitabine (X) combination therapy for HER2-positive metastatic breast cancer (MBC): efficacy and safety in a multinational phase II study
    Chan, A.
    Ganju, V.
    Becquart, D.
    Conte, P. F.
    Petruzelka, L.
    Goedhalss, L.
    Gil, M. Gil
    Bernardoe, G.
    Villanova, G.
    Tubiana-Mathieu, N.
    [J]. EJC SUPPLEMENTS, 2008, 6 (07): : 220 - 221
  • [4] Efficacy and safety of trastuzumab plus vinorelbine as second-line treatment for women with HER2-positive metastatic breast cancer beyond disease progression
    Bachelot, T.
    Mauriac, L.
    Delcambre, C.
    Maillart, P.
    Veyret, C.
    Mouret-Reynier, M.
    Van Praagh, I.
    Chollet, P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Efficacy of oral vinorelbine (NVBo), capecitabine (X) and trastuzumab (H) triple combination (NVBoXH) in HER2-positive metastatic breast cancer (MBC): First results of an international phase II trial
    Chan, A.
    Ganju, V.
    Becquart, D.
    Conte, P.
    Petruzelka, L.
    Aubert, D.
    Villanova, G.
    Tubiana-Mathieu, N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer
    Morabito, Alessandro
    Longo, Raffaele
    Gattuso, Domenico
    Carillio, Guido
    Massaccesi, Cristian
    Mariani, Luigi
    Bonginelli, Paola
    Amici, Scolastica
    De Sio, Livia
    Fanelli, Massimo
    Torino, Francesco
    Bonsignori, Maurizio
    Gasparini, Giampietro
    [J]. ONCOLOGY REPORTS, 2006, 16 (02) : 393 - 398
  • [7] A pooled analysis of efficacy and safety of vinorelbine in combination with capecitabine in first-line metastatic breast cancer (MBC)
    Valev, Spartak S.
    Taushanova, Margarita
    Krasteva, Ely
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 163 - 163
  • [8] ALL ORAL COMBINATION OF VINORELBINE AND CAPECITABILE AS A FIRST LINE TREATMENT IN PATIENTS (PTS) WITH METASTATIC BREAST CANCER (MBC)
    Shehata, Samir
    Khalaf, Marwa
    [J]. BREAST, 2017, 36 : S53 - S53
  • [9] All oral combination of vinorelbine and capecitabine as a first line treatment in patients (pts) with metastatic breast cancer (MBC)
    Shehata, S.
    Khalaf, M.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [10] Phase II study of lapatinib in combination with vinorelbine, as first- or second-line therapy in women with HER2-overexpressing metastatic breast cancer
    Chew, Helen K.
    Schwartzberg, Lee Steven
    Badarinath, Suprith
    Rubin, Peter
    Shumaker, Grace
    Daugherty, James P.
    DeSilvio, Michelle
    Mahoney, Janine M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345